Evidence map›Paper›PMID 36229877›Full record

ArticleAnnals of clinical microbiology and antimicrobials2022

Virulence, phenotype and genotype characteristics of invasive group B Streptococcus isolates obtained from Swedish pregnant women and neonates.

Emily M Huebner, Margrét Johansson Gudjónsdóttir, Matthew B Dacanay, Shayla Nguyen, Alyssa Brokaw, Kavita Sharma, Anders Elfvin, Elisabet Hentz, Ysabella Raceli Rivera, Nicole Burd and 10 more

Open access · goldAbstract read
In one paragraph

Article in Annals of clinical microbiology and antimicrobials, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed, 1 pooled it
1.2field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 1 synthesis or guideline pooled it, 6 citations in OpenAlex.

  1. Pooled it
  2. Adaptive microevolution in CC17Frontiers in cellular and infection microbiology · 2026
    Article
  3. Molecular epidemiology and antibiotic resistance of group BFrontiers in cellular and infection microbiology · 2025
    Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors at 5 institutions in 2 countries.

Emily M Huebner *School of Medicine, University of Washington, Seattle, WA, USA.
Margrét Johansson Gudjónsdóttir *Department of Pediatrics, Institute of Clinical Sciences, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.
Matthew B Dacanay *Department of Obstetrics and Gynecology, University of Washington, Seattle, WA, USA.
Shayla NguyenCenter for Global Infectious Disease Research, Seattle Children's Research Institute, Seattle, WA, USA.
Alyssa BrokawCenter for Global Infectious Disease Research, Seattle Children's Research Institute, Seattle, WA, USA.
Kavita SharmaCenter for Global Infectious Disease Research, Seattle Children's Research Institute, Seattle, WA, USA.
Anders ElfvinDepartment of Pediatrics, Institute of Clinical Sciences, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.
Elisabet HentzDepartment of Pediatrics, Institute of Clinical Sciences, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.
Ysabella Raceli RiveraDepartment of Obstetrics and Gynecology, University of Washington, Seattle, WA, USA.
Nicole BurdDepartment of Obstetrics and Gynecology, University of Washington, Seattle, WA, USA.
Megana ShivakumarDepartment of Obstetrics and Gynecology, University of Washington, Seattle, WA, USA.
Brahm ColerDepartment of Obstetrics and Gynecology, University of Washington, Seattle, WA, USA.
Miranda LiDepartment of Obstetrics and Gynecology, University of Washington, Seattle, WA, USA.
Amanda LiDepartment of Obstetrics and Gynecology, University of Washington, Seattle, WA, USA.
Jeff MunsonDepartment of Psychiatry and Behavior Sciences, University of Washington, Seattle, WA, USA.
Austyn OrvisCenter for Global Infectious Disease Research, Seattle Children's Research Institute, Seattle, WA, USA.
Michelle ColemanCenter for Global Infectious Disease Research, Seattle Children's Research Institute, Seattle, WA, USA.
Bo JacobssonDepartment of Pediatrics, Region Västra Götaland, Sahlgrenska University Hospital, Gothenburg, Sweden.
Lakshmi RajagopalCenter for Global Infectious Disease Research, Seattle Children's Research Institute, Seattle, WA, USA.
Kristina M Adams WaldorfDepartment of Obstetrics and Gynecology, University of Washington, Seattle, WA, USA. adamsk@uw.edu.
University of Washington · USInfectious Disease Research Institute · USSahlgrenska University Hospital · SEUniversity of Gothenburg · SERegion Västra Götaland · SE

Funding

Diseases of Public Health Importance Training GrantT32AI007509 · NIAID · UNIVERSITY OF WASHINGTON · PI LUND, JENNIFER M · 1997 to 2024
$6.3M
Role of the hyaluronidase in GBS VirulenceR01AI133976 · NIAID · SEATTLE CHILDREN'S HOSPITAL · PI ADAMS WALDORF, KRISTINA M., RAJAGOPAL, LAKSHMI · 2017 to 2021
$4.5M
Immune Control of Group B Streptococcal PlacentalR01AI145890 · NIAID · SEATTLE CHILDREN'S HOSPITAL · PI ADAMS WALDORF, KRISTINA M., RAJAGOPAL, LAKSHMI · 2019 to 2023
$4.4M
Targeted Inhibition of Interleukin-1 beta to Prevent Preterm BirthR01HD098713 · NICHD · UNIVERSITY OF WASHINGTON · PI ADAMS WALDORF, KRISTINA M., RAJAGOPAL, LAKSHMI · 2020 to 2024
$3.8M
ALF-agreement ALFGBG 882171, 117661 and 717501Eunice Kennedy Shriver National Institute of Child Health and Human Development AI133976National Institute of Allergy and Infectious Diseases AI145890NCRR NIH HHS HD098713NIAID NIH HHS R01 AI133976NIAID NIH HHS R01 AI145890NIAID NIH HHS T32 AI007509NICHD NIH HHS R01 HD098713
6 · The paper itself

Abstract

Group B streptococci (GBS) are bacteria that can cause preterm birth and invasive neonatal disease. Heterogeneous expression of virulence factors enables GBS to exist as both commensal bacteria and to become highly invasive. A molecular epidemiological study comparing GBS bacterial traits, genotype and host characteristics may indicate whether it is possible to predict the risk of perinatal invasive GBS disease and more accurately target intrapartum antibiotic prophylaxis. A total of 229 invasive GBS isolates from Swedish pregnant women or neonates were assessed for virulence and phenotypic traits: hemolysis zone, hemolytic pigment (Granada agar), Streptococcus B Carrot Broth (SBCB) assay, CAMP factor, and hyaluronidase activity. Genes regulating hemolytic pigment synthesis (covR/covS, abx1, stk1, stp1) were sequenced. Of the virulence factors and phenotypes assessed, a Granada pigment or SBCB score ≥ 2 captured more than 90% of EOD isolates with excellent inter-rater reliability. High enzyme activity of hyaluronidase was observed in 16% (36/229) of the invasive GBS isolates and notably, in one case of stillbirth. Hyaluronidase activity was also significantly higher in GBS isolates obtained from pregnant/postpartum individuals versus the stillbirth or neonatal invasive isolates (p < 0.001). Sequencing analysis found that abx1 (g.T106I), stk1 (g.T211N), stp1 (g.K469R) and covS (g.V343M) variants were present significantly more often in the higher (Granada pigment score ≥ 2) versus lower pigmented isolates (p < 0.001, each variant). Among the 203 higher Granada pigment scoring isolates, 22 (10.8%) isolates had 3 of the four sequence variants and 10 (4.9%) had 2 of the four sequence variants. Although heterogeneity in GBS virulence factor expression was observed, the vast majority were more highly pigmented and contained several common sequence variants in genes regulating pigment synthesis. High activity of hyaluronidase may increase risk for stillbirth and invasive disease in pregnant or postpartum individuals. Our findings suggest that testing for GBS pigmentation and hyaluronidase may, albeit imperfectly, identify pregnant people at risk for invasive disease and represent a step towards a personalized medical approach for the administration of intrapartum antibiotic prophylaxis.

Indexed as

Premature BirthStreptococcal InfectionsAgarAnti-Bacterial AgentsFemaleGenotypeHumansHyaluronoglucosaminidaseInfant, NewbornPhenotypePregnancyPregnant PeopleReproducibility of ResultsStillbirthStreptococcus agalactiaeSwedenAgarAnti-Bacterial AgentsHyaluronoglucosaminidaseVirulence FactorsEarly-onset diseaseGroup B StreptococcusLate-onset diseaseNeonatePregnancyPreterm birthPreterm laborStreptococcus agalactiae

Identifiers

PMID36229877
PMCPMC9560721
OpenAlexW4306147121

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.